HIV Diagnosis & Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers HIV Diagnostics Market Trends, Forecast & Growth and the market is segmented by Product (Consumables, Instruments, and Software & Services), Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, and Others), End User (Diagnostic Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

HIV Diagnosis & Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

HIV/AIDS Diagnostics Market Size

HIV/AIDS Diagnostics Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 5.02 Billion
Market Size (2030) USD 8.22 Billion
CAGR (2025 - 2030) 10.35 %
Fastest Growing Market Africa
Largest Market North America
Market Concentration Medium

Major Players

HIV/AIDS Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global HIV/AIDS Diagnostics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

HIV/AIDS Diagnostics Market Analysis

The Global HIV/AIDS Diagnostics Market size is estimated at USD 5.02 billion in 2025, and is expected to reach USD 8.22 billion by 2030, at a CAGR of 10.35% during the forecast period (2025-2030).

COVID-19 caused a dramatic decline in HIV testing and, as a consequence, a much lower number of new HIV diagnoses. In May 2022, an article published titled "COVID Caused Drop-in HIV Testing, Diagnoses" stated that the Centers for Disease Control and Prevention (CDC) 2020 HIV surveillance report showed COVID disruptions. The COVID-19 pandemic in the United States led to disruptions in HIV testing services and access to clinical services throughout 2020. This disruption resulted in a steep, single-year decline in HIV diagnoses that is mostly attributed to declines in testing caused by less frequent visits to health centers, reduced outreach services, and shifting of public health staff to COVID-19 response activities. Similarly, in December 2021, a report published by the Government of Canada, titled "HIV in Canada: 2020 Surveillance highlights" stated that the COVID-19 pandemic resulted in a decreased demand for, and ability to provide, services related to sexually transmitted and bloodborne infections, including HIV testing. This may have had an impact on observed new diagnosis rates for HIV in 2020. Hence, the COVID-19 pandemic has a negative impact on market growth. However, in the future, the market is likely to grow.

Factors such as the increasing prevalence of HIV along with new initiatives and product launches are the primary reasons for the growth of the market. According to the World Health Organization (WHO) update in November 2021, HIV continues to be a major global public health issue, having claimed 36.3 million lives so far. There were an estimated 37.7 million (30.2-45.1 million) people living with HIV at the end of 2020, over two-thirds of whom (25.4 million) are in the WHO African Region. In 2020, 680,000 (480,000-1.0 million) people died from HIV-related causes and 1.5 million (1.0-2.0 million) people acquired HIV.

The increasing initiatives by public organizations such as United Nations Programme on HIV and AIDS. (UNAIDS) provides awareness and investments to the market. To reach the new proposed global 95-95-95 targets set by UNAIDS, to avoid the worst-case scenario of 7.7 million HIV-related deaths over the next 10 years, increasing HIV infections due to HIV service disruptions during COVID-19, and the slowing public health response to HIV. Such initiatives increase awareness which increases the demand for more diagnostic tests which increases the growth of the market.

Furthermore, the new research and developments, technological innovations, and the launch of technologically advanced products by key players are expected to boost the growth of the market. For instance, in April 2021, Altona Diagnostics launched an in-vitro diagnostic test based on real-time RT-PCR technology that detects and quantifies the human immunodeficiency virus (HIV) specific RNA in human plasma. The test was named as AltoStar HIV RT-PCR Kit 1.5. Therefore, due to the above-stated factors, the studied market is anticipated to witness notable growth during the study period.

However, the lack of mandates for nucleic acid tests in developing countries is likely to hinder market growth.

HIV/AIDS Diagnostics Industry Overview

The HIV/AIDS diagnostics market is moderately competitive and consists of several major players. Some of the market players are Siemens Healthineers, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Hologic Inc., and Bio-Rad Laboratories among others.

HIV/AIDS Diagnostics Market Leaders

  1. Siemens Healthineers

  2. F. Hoffmann-La Roche Ltd

  3. Abbott Laboratories

  4. Thermo-Fisher Scientific Inc.

  5. Danaher Corporation

  6. *Disclaimer: Major Players sorted in no particular order
HIV/AIDS Diagnostics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

HIV/AIDS Diagnostics Market News

  • In May 2022, THE Amref Health Africa-Tanzania launched the 'Afya Kamilifu' project in Mara Region to prevent HIV. The project is sponsored by the Centre for Disease Control and Prevention (CDC). Under this HIV self-test kits were made available at all health centers in the region.
  • In May 2022, Roche through its Global Access Program, partnered with The Global Fund to improve the diagnosis of HIV by building local capacity to tackle fundamental infrastructure challenges for generating and delivering diagnostic results and managing healthcare waste. This includes building effective processes to collect, transport, test samples, and return the results to patients for timely clinical interventions, as well as addressing challenges arising from a lack of network infrastructure, workforce capacity, access to roads, and IT systems.

HIV/AIDS Diagnostics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of HIV/Aids globally
    • 4.2.2 Increasing Government Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Lack of Mandates for Nucliec acid test in Developing Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Consumables
    • 5.1.2 Instruments
    • 5.1.3 Software & Services
  • 5.2 By Test Type
    • 5.2.1 Antibody Tests
    • 5.2.2 Viral Load Tests
    • 5.2.3 CD4 Tests
    • 5.2.4 Others
  • 5.3 By End User
    • 5.3.1 Diagnostic Laboratories
    • 5.3.2 Hospitals
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Siemens Healthineers
    • 6.1.2 F. Hoffmann-La Roche Ltd
    • 6.1.3 Abbott Laboratories
    • 6.1.4 Danaher Corporation
    • 6.1.5 Thermo-Fisher Scientific Inc.
    • 6.1.6 Merck KGaA
    • 6.1.7 Becton, Dickinson & Company
    • 6.1.8 Hologic Inc.
    • 6.1.9 Bio-Rad Laboratories
    • 6.1.10 OraSure Technologies
    • 6.1.11 Chembio Diagnostics, Inc.
    • 6.1.12 Omega Diagnostics Group PLC
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

HIV/AIDS Diagnostics Industry Segmentation

As per the scope of the report HIV/AIDS diagnostics are used to investigate the existence of the human immune-deficiency virus, in saliva, serum or urine. HIV/AIDS diagnostics helps to detect antibodies, RNA or antigens. Blood tests are the most regular way to make a diagnosis of HIV. HIV is most commonly diagnosed by doing a urine test and blood test. The HIV/AIDS Diagnostics Market is Segment by Product (Consumables, Instruments, and Software & Services), Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, and Others), End User (Diagnostic Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Consumables
Instruments
Software & Services
By Test Type Antibody Tests
Viral Load Tests
CD4 Tests
Others
By End User Diagnostic Laboratories
Hospitals
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

HIV/AIDS Diagnostics Market Research FAQs

How big is the Global HIV/AIDS Diagnostics Market?

The Global HIV/AIDS Diagnostics Market size is expected to reach USD 5.02 billion in 2025 and grow at a CAGR of 10.35% to reach USD 8.22 billion by 2030.

What is the current Global HIV/AIDS Diagnostics Market size?

In 2025, the Global HIV/AIDS Diagnostics Market size is expected to reach USD 5.02 billion.

Who are the key players in Global HIV/AIDS Diagnostics Market?

Siemens Healthineers, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo-Fisher Scientific Inc. and Danaher Corporation are the major companies operating in the Global HIV/AIDS Diagnostics Market.

Which is the fastest growing region in Global HIV/AIDS Diagnostics Market?

Africa is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global HIV/AIDS Diagnostics Market?

In 2025, the North America accounts for the largest market share in Global HIV/AIDS Diagnostics Market.

What years does this Global HIV/AIDS Diagnostics Market cover, and what was the market size in 2024?

In 2024, the Global HIV/AIDS Diagnostics Market size was estimated at USD 4.50 billion. The report covers the Global HIV/AIDS Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global HIV/AIDS Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

HIV Diagnosis & Treatment Industry Report

Statistics for the 2025 Global HIV/AIDS Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global HIV/AIDS Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

HIV Diagnosis & Treatment Market Report Snapshots